Inventor
KANKANALA JAYAKANTH
US17 patents
⚠️ This page may combine multiple inventors who share the name “KANKANALA JAYAKANTH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NUVATION BIO INC
16 patentsUS11292782B2Apr 5, 2022
Diarylhydantoin compounds and methods of use thereof
NUVATION BIO INC6 citations73
US11826430B2Nov 28, 2023
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC2 citations71
US11584756B2Feb 21, 2023
Heterocyclic compounds as BET inhibitors
NUVATION BIO INC3 citations71
US11034669B2Jun 15, 2021
Pyrrole and pyrazole compounds and methods of use thereof
NUVATION BIO INC6 citations71
US12006314B2Jun 11, 2024
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC2 citations70
US11834458B2Dec 5, 2023
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC2 citations70
US10807994B2Oct 20, 2020
Heterocyclic compounds and uses thereof
NUVATION BIO INC3 citations68
US12208141B2Jan 28, 2025
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC0 citations61
US11952349B2Apr 9, 2024
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC2 citations59
US11299493B2Apr 12, 2022
Heterocyclic compounds and uses thereof
NUVATION BIO INC0 citations58
US11174252B2Nov 16, 2021
Heterocyclic compounds as kinase inhibitors
NUVATION BIO INC1 citations57
US11306071B2Apr 19, 2022
Heterocyclic compounds as adenosine antagonists
NUVATION BIO INC0 citations56
US12398121B2Aug 26, 2025
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC0 citations50
US11192900B2Dec 7, 2021
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
NUVATION BIO INC0 citations50
US11332473B2May 17, 2022
Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors
NUVATION BIO INC0 citations46
US11254670B2Feb 22, 2022
1,8-naphthyridinone compounds and uses thereof
NUVATION BIO INC0 citations46